Bacteria Test Developer Reiterates Revenue Should Double in 2019
Source: Streetwise Reports  (6/5/19)
The product expected to drive that outcome is discussed in an H.C. Wainwright & Co. report. More >

Healthcare Firm Partners on Genetic Testing for Cannabis, Medication Responses
Source: Streetwise Reports  (6/3/19)
The offering should facilitate a more individualized treatment plan for patients. More >

Health Tech Firm to Pilot Artificial Intelligence-Powered Patient Monitoring Tool
Source: Streetwise Reports  (4/24/19)
This effort is one way the company can innovatively offer patients care. More >

Biotech Achieves Development Milestone for Blue Light Imaging System
Source: Streetwise Reports  (4/5/19)
The surgical imaging firm continues to advance its first medical device toward commercialization. More >

Innovative Healthcare Tech Firm to Acquire Two Vancouver Pharmacies
Source: Streetwise Reports  (4/3/19)
The transaction will allow the company to add a prescription fill and fulfillment component to its telemedicine app. More >

Firm Signs Paid Pilot Agreements to Test Telemedicine Platform in 5 States
Source: Streetwise Reports  (3/30/19)
With this development, the Canadian company further expands its U.S. footprint. More >

Premier Health Group Adding Medical Cannabis Support Tool
Source: Streetwise Reports  (3/27/19)
This clinical decision support software integration is the first of its kind, according to the company. More >

5 Small-Caps on Fund Manager Steve Palmer's Radar Screen
Source: Streetwise Reports  (3/19/19)
Steve Palmer, Founding Partner, President and Chief Investment Officer for AlphaNorth Asset Management, talks about a handful of companies in diverse industries that have his attention. More >

Health Tech Firm Completes Enrollment for Female Sexual Function Trial
Source: Streetwise Reports  (3/15/19)
A Ladenburg Thalmann report reviewed the study design and purpose. More >

Anixa Doesn't Disappoint
Source: Daniel Carlson for Streetwise Reports  (1/29/19)
Daniel Carlson of Tailwinds Research explains why he has designated this company his 2019 stock of the year. More >

Biotech Enters License Agreement to Validate Biomarker as Alternative NASH Diagnostic
Source: Streetwise Reports  (1/5/19)
The background and justification for the deal was covered in an H.C. Wainwright & Co. report. More >

Telehealth Services Provider's Positive Q3/18 Results Reflect 'Robust Growth Rate'
Source: Streetwise Reports  (12/12/18)
A William Blair report reviewed the firm's operational and financial numbers for the period. More >

Health Stock 'Looking Set to Bounce Back After 90% Drop'
Source: Clive Maund for Streetwise Reports  (12/11/18)
Technical analyst Clive Maund charts a telemedicine technology company and explains why he believes the company's stock should rebound. More >

Biotech to Expand Precision Medicine Services via New Partnership
Source: Streetwise Reports  (10/24/18)
A Maxim Group report discussed the potential implications of this new collaboration in the field of personalized medicine and oncology. More >

Developer of Nitric Oxide Delivery Devices Rebrands to Focus on Leading Advancements
Source: Streetwise Reports  (10/9/18)
This Utah-based company rolled out an online campaign that highlights its strategic repositioning. More >

Interim Readout for Pharma Trial 'Delivers Home Run'
Source: Streetwise Reports  (7/31/18)
An H.C. Wainwright & Co. report discussed the implications of data indicating "overwhelming evidence of efficacy" for this company's nonantibiotic anti-infective for treatment of catheter-related bloodstream infections. More >

Healthcare Tech Company Receives US Patent
Source: Streetwise Reports  (7/19/18)
The U.S Patent and Trademark Office has granted the allowance to a technology company whose platform allows healthcare organizations to buy, sell and trade equipment and supplies. More >

Convergence Will Drive the Ultimate Disruption of Life Sciences
Source: Andrea Bartzen for Streetwise Reports  (3/28/18)
Andrea Bartzen, a strategic commercial and communication consultant, describes the disruptive technologies positioned to radically alter the business of life sciences as discussed at a recent BIO CEO Summit Investor Night.
More >

Exciting Biotech Stock Now Breaking Out of Large Base
Source: Clive Maund for Streetwise Reports  (3/5/18)
Technical analyst Clive Maund takes a look at a biotech stock that he views as a strong buy. More >

Fund Manager Names Three Small-Caps with Strong Growth Profiles
Source: Streetwise Reports  (2/22/18)
The annual AlphaNorth Capital Conference features small-cap non-resource companies with high growth prospects. AlphaNorth's founder and chief investment officer, Steve Palmer, profiles several companies that he believes have bright prospects.
More >

Can a Simple Test Really Predict Whether a Cancer Treatment Will Succeed?
Source: Streetwise Reports  (2/20/18)
Imagine if a simple test of a blood or tissue sample could predict whether the standard treatment of care for a cancer would be effective. That day appears to be near for patients with Hodgkin's lymphoma. More >

Company Takes Aim at Approval of Colorectal Cancer Screening Test in EU
Source: Streetwise Reports  (2/13/18)
Two analysts take note as this biotech prepares to release data on its colorectal cancer screening product.
More >

Could a FDA Warning Letter Provide a Silver Lining to This Home Care Medical Device Company?
Source: Maj Soueidan for Streetwise Reports  (11/6/17)
Maj Soueidan, cofounder of GeoInvesting, profiles his long history with a company providing medical devices for the home care market. More >

2017 Small-Cap Biotech Watchlist Update: Up 21% at the End of Q2/17
Source: Streetwise Reports  (7/13/17)
If an investor had purchased an equal dollar amount of each company on The Life Sciences Report's 2017 Small-Cap Biotech Watchlist at the beginning of the year, that portfolio would show a gain of about 21% as of July. This is primarily due to the performance of a handful of companies that have been moving their assets farther down the development pipeline, according to the analysts who follow them. More >

Neuromonitoring Company Founded by Former NFL Quarterback Set to Go Public
Source: The Life Sciences Report  (5/26/17)
Assure Holdings, an intraoperative neuromonitoring company founded by former NFL quarterback Preston Parsons, will begin trading on the TSX Venture Exchange on May 29, under the trading symbol IOM. More >